HIT-6 Responder Rates after 1 and 3 Months of Eptinezumab Treatment

Lipton, RB; McGinley, JS; Hirman, J; Wirth, R; Houts, CR; Cady, R

CEPHALALGIA, 2019; 39 (): 12